Cx Institutional Pfizer Inc Transaction History

Cx Institutional

$3.29 Billion
Q3 2025

A detailed history of Cx Institutional transactions in Pfizer Inc stock. As of the latest transaction made, Cx Institutional holds 35,873 shares of PFE stock, worth $871,355. This represents 0.03% of its overall portfolio holdings.

Number of Shares

35,873

Previous 47,032 23.73%

Holding current value

$871,355

Previous $1.14 Million 19.82%

% of portfolio

0.03%

Previous 0.04%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 23, 2025	SELL	$23.29 - $25.88 $259,893 - $288,794	-11,159 Reduced 23.73%	35,873 $914,000
Q2 2025 Jul 11, 2025	BUY	$21.59 - $24.84 $341,057 - $392,397	15,797 Added 50.57%	47,032 $1.14 Million
Q1 2025 Apr 15, 2025	SELL	$25.01 - $27.13 $479,066 - $519,675	-19,155 Reduced 38.01%	31,235 $791,000
Q4 2024 Jan 21, 2025	BUY	$24.8 - $30.19 $103,738 - $126,284	4,183 Added 9.05%	50,390 $1.34 Million
Q3 2024 Oct 11, 2024	BUY	$27.7 - $31.39 $569,290 - $645,127	20,552 Added 80.11%	46,207 $1.34 Million
Q2 2024 Jul 11, 2024	SELL	$25.26 - $29.6 $616,419 - $722,328	-24,403 Reduced 48.75%	25,655 $717,000
Q1 2024 Apr 15, 2024	SELL	$25.89 - $29.73 $1.55 Million - $1.78 Million	-59,800 Reduced 54.43%	50,058 $1.39 Million
Q4 2023 Jan 12, 2024	BUY	$26.13 - $33.94 $147,033 - $190,980	5,627 Added 5.4%	109,858 $3.16 Million
Q3 2023 Oct 17, 2023	BUY	$32.09 - $37.51 $1.82 Million - $2.13 Million	56,661 Added 119.11%	104,231 $3.46 Million
Q2 2023 Jul 26, 2023	SELL	$36.12 - $41.79 $250,672 - $290,022	-6,940 Reduced 12.73%	47,570 $1.74 Million
Q1 2023 May 04, 2023	SELL	$39.39 - $51.28 $7,878 - $10,256	-200 Reduced 0.37%	54,510 $2.22 Million
Q4 2022 Feb 03, 2023	BUY	$41.75 - $54.5 $419,921 - $548,161	10,058 Added 22.53%	54,710 $2.8 Million
Q3 2022 Nov 04, 2022	SELL	$43.76 - $53.42 $2.46 Million - $3 Million	-56,135 Reduced 55.7%	44,652 $1.95 Million
Q2 2022 Aug 02, 2022	BUY	$46.53 - $55.17 $660,586 - $783,248	14,197 Added 16.4%	100,787 $5.28 Million
Q1 2022 May 09, 2022	SELL	$45.75 - $56.69 $926,803 - $1.15 Million	-20,258 Reduced 18.96%	86,590 $4.48 Million
Q4 2021 Jan 18, 2022	BUY	$41.32 - $61.25 $2.99 Million - $4.43 Million	72,378 Added 209.97%	106,848 $6.31 Million
Q3 2021 Nov 10, 2021	SELL	$39.25 - $50.42 $1.25 Million - $1.6 Million	-31,788 Reduced 47.98%	34,470 $1.48 Million
Q2 2021 Aug 04, 2021	BUY	$35.91 - $40.68 $110,171 - $124,806	3,068 Added 4.86%	66,258 $2.6 Million
Q1 2021 Apr 15, 2021	SELL	$33.49 - $37.77 $1.13 Million - $1.27 Million	-33,678 Reduced 34.77%	63,190 $2.29 Million
Q4 2020 Jan 12, 2021	SELL	$33.47 - $42.56 $443,276 - $563,664	-13,244 Reduced 12.03%	96,868 $3.57 Million
Q3 2020 Oct 13, 2020	BUY	$31.75 - $37.25 $2.65 Million - $3.1 Million	83,315 Added 310.91%	110,112 $4.04 Million
Q2 2020 Aug 06, 2020	SELL	$30.12 - $36.54 $11,566 - $14,031	-384 Reduced 1.41%	26,797 $876,000
Q1 2020 Apr 29, 2020	BUY	$27.03 - $38.62 $31,219 - $44,606	1,155 Added 4.44%	27,181 $887,000
Q4 2019 Jan 21, 2020	SELL	$32.92 - $37.36 $3,588 - $4,072	-109 Reduced 0.42%	26,026 $1.02 Million
Q3 2019 Oct 10, 2019	BUY	$32.49 - $42.13 $4,126 - $5,350	127 Added 0.49%	26,135 $939,000
Q2 2019 Jul 17, 2019	SELL	$36.98 - $41.52 $109,497 - $122,940	-2,961 Reduced 10.22%	26,008 $1.13 Million
Q1 2019 Apr 03, 2019	BUY	$37.5 - $41.2 $195,637 - $214,940	5,217 Added 21.96%	28,969 $1.23 Million
Q4 2018 Jan 14, 2019	SELL	$38.47 - $43.86 $527,077 - $600,925	-13,701 Reduced 36.58%	23,752 $1.04 Million
Q3 2018 Oct 09, 2018	BUY	$34.47 - $41.81 $48,120 - $58,366	1,396 Added 3.87%	37,453 $1.65 Million
Q2 2018 Jul 12, 2018	BUY	$32.98 - $35.16 $410,073 - $437,179	12,434 Added 52.64%	36,057 $1.31 Million
Q2 2018 Jul 12, 2018	BUY	$32.98 - $35.16 $779,086 - $830,584	23,623 New	23,623 $838,000

Others Institutions Holding PFE

# of Institutions

3,309

Shares Held

3.65B

Call Options Held

96.5M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $136B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cx Institutional, based on Form 13F filings with the SEC.

News

Stay updated on Cx Institutional with notifications on news.

Account

Cx Institutional Pfizer Inc Transaction History